Top American pharmaceutical firm Amgen (AMGN) on Monday unwrapped AmgenNow, its new direct-to-consumer platform. It kicked off the launch with a 60% discount on its popular cholesterol-reducing injection, Repatha. However, investors appear unimpressed with the move, with AMGN stock trending lower on Friday afternoon. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, …
Read More »Amgen Stock (AMGN) Falls as It Cuts 60% Off Cholesterol Drug Price, Heeding Trump’s Clamor
